ArticleDiabetes & metabolism journal2024

SGLT2 Inhibitors and GLP-1 Agonists: A Beacon of Hope for Stroke Prevention in Diabetes.

Jae-Han JeonPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.